During the past decade, Cytecare Hospitals Pvt. Ltd conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cytecare Hospitals Pvt. Ltd" are "Leukemia, Lymphocytic, Chronic, B-Cell" (1 trials), "Lymphoma, Mantle-Cell" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Cytecare Hospitals Pvt. Ltd" in a lesser frequency.

Most popular intervention types in "Cytecare Hospitals Pvt. Ltd" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Daratumumab" (1 trials), "Ibrutinib 420 mg" (1 trials) and "Ibrutinib 560 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cytecare Hospitals Pvt. Ltd" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cytecare Hospitals Pvt. Ltd". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cytecare Hospitals Pvt. Ltd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cytecare Hospitals Pvt. Ltd, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".